These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31591834

  • 1. Clinical Efficacy and Safety of Injectable Levetiracetam Versus Phenytoin as Second-Line Therapy in the Management of Generalized Convulsive Status Epilepticus in Children: An Open-Label Randomized Controlled Trial.
    Noureen N, Khan S, Khursheed A, Iqbal I, Maryam M, Sharib SM, Maheshwary N.
    J Clin Neurol; 2019 Oct; 15(4):468-472. PubMed ID: 31591834
    [Abstract] [Full Text] [Related]

  • 2. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE, Rainford NE, Gamble C, Messahel S, Humphreys A, Hickey H, Woolfall K, Roper L, Noblet J, Lee E, Potter S, Tate P, Al Najjar N, Iyer A, Evans V, Lyttle MD.
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR, Furyk J, Bonisch M, Oakley E, Borland M, Neutze J, Donath S, Sharpe C, Harvey S, Davidson A, Craig S, Phillips N, George S, Rao A, Cheng N, Zhang M, Sinn K, Kochar A, Brabyn C, Babl FE, PREDICT research network.
    BMC Pediatr; 2017 Jun 22; 17(1):152. PubMed ID: 28641582
    [Abstract] [Full Text] [Related]

  • 5. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, Woolfall K, Roper L, Noblet J, Lee ED, Potter S, Tate P, Iyer A, Evans V, Appleton RE, Paediatric Emergency Research in the United Kingdom & Ireland (PERUKI) collaborative.
    Lancet; 2019 May 25; 393(10186):2125-2134. PubMed ID: 31005385
    [Abstract] [Full Text] [Related]

  • 6. Intravenous levetiracetam versus intravenous phenytoin as second Line treatment in pediatric convulsive status epilepticus- open label randomized controlled trial.
    Kartek M, Kannan A, Anand V, Sahoo MR.
    J Family Med Prim Care; 2024 Aug 25; 13(8):3368-3373. PubMed ID: 39228645
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V, Rameshkumar R, Mahadevan S.
    Indian Pediatr; 2020 Mar 15; 57(3):222-227. PubMed ID: 32198861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
    Lyttle MD, Gamble C, Messahel S, Hickey H, Iyer A, Woolfall K, Humphreys A, Bacon NEA, Roper L, Babl FE, Dalziel SR, Ryan M, Appleton RE, supported by Paediatric Emergency Research in the United Kingdom & Ireland (PERUKI).
    Trials; 2017 Jun 19; 18(1):283. PubMed ID: 28629473
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Angurana SK, Suthar R.
    J Trop Pediatr; 2021 May 17; 67(2):. PubMed ID: 34089322
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levetiracetam versus phenytoin in children with status epilepticus.
    Wani G, Imran A, Dhawan N, Gupta A, Giri JI.
    J Family Med Prim Care; 2019 Oct 17; 8(10):3367-3371. PubMed ID: 31742170
    [Abstract] [Full Text] [Related]

  • 16. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
    Nakamura K, Marushima A, Takahashi Y, Kimura A, Asami M, Egawa S, Kaneko J, Kondo Y, Yonekawa C, Hoshiyama E, Yamada T, Maruo K, Inoue Y, IENE ECT with the LIFE study group.
    Trials; 2021 May 02; 22(1):317. PubMed ID: 33934714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A, Kneen R, Kumar R, Spinty S, Appleton R.
    Seizure; 2012 Sep 02; 21(7):529-34. PubMed ID: 22722010
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Convulsive Status Epilepticus.
    Grover EH, Nazzal Y, Hirsch LJ.
    Curr Treat Options Neurol; 2016 Mar 02; 18(3):11. PubMed ID: 26920416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.